Background: Tablet computers are generally associated with an intuitive interface. The adoption and use of tablet computers within the early-stage dementia context could potentially assist in daily living and provide users with a source for leisure activities and social networking. As dementia mainly affects the older adult population, it is expected that many people with dementia and even their carers do not use tablet computers as part of their everyday living. Objective: This paper explores the usability of tablet computers within the early-stage dementia context as a source of leisure for people with dementia. The main advantage of the use of tablet computers in this manner is to provide carers some reprieve from the constant care and attention often required in caring for people with dementia. Methods: Seven-day in-home trials were conducted to determine whether people with early-stage dementia were -capable of using a tablet computer independently. Twenty-one people with early-stage dementia and carer dyads participated in the trial. Feedback was gathered through questionnaires from both the person with dementia and their carer regarding the use of a tablet computer as part of their everyday living. Results: Approximately half the participants with dementia were able to engage with and use the tablet computer independently, which proved to be helpful to their carers. No significant traits were observed to help identify those who were less likely to use a tablet computer. Carer relief was quantified by the amount of time participants with dementia spent using the device without supervision. Conclusions: The results and feedback from the trial provide significant insights to introducing new technology within the early-stage dementia context. Users' needs must be considered on a case-by-case basis to successfully facilitate the uptake of tablet computers in the dementia context. The trial has provided sufficient justification to further explore more uses of tablet computers in the dementia context, and not just for early-stage dementia.

1.
World Alzheimer's Report 2010 - The Global Economic Impact of Dementia. Alzhei-mer's Disease International, London, 2011.
2.
Burns A, Rabins P: Carer burden in dementia. Int J Geriatr Psychiatry 2000;15:S9-S13.
3.
Raccichini A, Castellani S, Civerchia P, Fioravanti P, Scarpino O: The caregiver's burden of Alzheimer patients: differences between live-in and non-live-in. Am J Alz-heimers Dis Other Demen 2009;24:377-383.
4.
Karlin NJ, Bell PA, Noah JL: Long-term consequences of the Alzheimer's caregiver role: a qualitative analysis. Am J Alzheimers Dis Other Demen 2001;16:177-182.
5.
Wey S: One size does not fit all: person-centred approaches to the use of assistive technology; in M Marshall (ed): Perspectives on Rehabilitation and Dementia. London, Jessica Kingsley Publishers, 2006, pp 202-208.
6.
Lewis ML, Hobday JV, Hepburn KW: Internet-based program for dementia caregivers. Am J Alzheimers Dis Other Demen 2010;25:674-679.
7.
Glueckauf RL, Ketterson TU, Loomis JS, Dages P: Online support and education for dementia caregivers: overview, utilization, and initial program evaluation. Telemed J E Health 2004;10:223-232.
8.
Chambers MG, Connor SL, McGonigle M, Diver MG: Multimedia software to help caregivers cope. J Am Med Inform Assoc 2003;10:504-511.
9.
Alm N, Astell A, Gowans G, Dye R, Ellis M, Vaughan P, Riley P: Engaging multimedia leisure for people with dementia. Gerontechnology 2009;8:236-246.
10.
Astell AJ, Ellis MP, Bernardi L, Alm N, Dye R, Gowans G, Campbell J: Using a touch screen computer to support relationships between people with dementia and caregivers. Interact Comput 2010;22:267-275.
11.
Riley P, Alm N, Newell A: An interactive tool to promote musical creativity in people with dementia. Comput Human Behav 2009;25:599-608.
12.
Wherton JP, Monk AF: Technological opportunities for supporting people with dementia who are living at home. Int J Hum Comput Stud 2008;66:571-586.
13.
Feist F, Parker K, Howard N, Hugo G: New technologies: their potential role in linking rural older people to community. Int J Emerg Technol Soc 2010;8:68-84.
14.
Naumann AB, Hurtienne J, Göllner S, Langdon MP, Clarkson PJ: Technology supporting the everyday life of people with dementia. Proceedings of the Conference on Inclusive Design - The Role of Inclusive Design in Making Social Innovation Happen, London, April 2011.
15.
Lindenberger U, Lövdén M, Schellenbach M, Li S-C, Krüger A: Psychological principles of successful aging technologies: a mini-review. Gerontology 2008;54:59-68.
16.
Schreiber M, Schweizer A, Lutz K, Kalveram KT, Jäncke L: Potential of an interactive computer-based training in the rehabilitation of dementia: an initial study. Neuropsychol Rehabil 1999;9:155-167.
17.
Flynn D, van Schaik P, Blackman T, Femcott C, Hobbs B, Calderon C: Developing a virtual reality-based methodology for people with dementia: a feasibility study. Cyberpsychol Behav 2003;6:591-611.
18.
Hofmann M, Rösler A, Schwarz W, Müller-Spahn F, Kräuchi K, Hock C, Seifritz E: Interactive computer-training as a therapeutic tool in Alzheimer's disease. Compr Psychiatry 2003;44:213-219.
19.
Reisberg B, Ferris SH, de Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
20.
Gartner: Gartner says Apple will have a free run in tablet market holiday season as competitors continue to lag. http://www.gartner.com/it/page.jsp?id=1800514 (accessed June 7, 2012).
21.
Raglio A, Bellelli G, Traficante D, Gianotti M, Ubezio MC, Villani D, Trabucchi M: Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheimer Dis Assoc Disord 2008;22:158-162.
22.
Rusted J, Sheppard L, Waller D: A multi-centre randomized control group trial on the use of art therapy for older people with dementia. Group Analysis 2006;39:517-536.
23.
Melenhorst A, Rogers WA, Bouwhuis DG: Older adults' motivated choice for technological innovation: evidence for benefit-driven selectivity. Psychol Aging 2006;21:190-195.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.